PATENT CLAIM ANALYSIS

Application Number: 15779480
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "248000"]

Abstract:
Described herein are pharmaceutical formulations comprising 4-fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide, or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical formulations are suitable for topical use, and methods of using such formulations in the treatment of subjects having cancer.

Claim (Index 7):
The topical formulation of  claim 1 , wherein the one or more gelling agents are present in an amount of from about 0.5% w/w to about 10% w/w.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.34146
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12815439', '13590481', '13509442', '13128726', '15120048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7669867672571578
- 35 USC 102 Novelty (BERT): 0.5394798899858094
- Combined Prediction Score: 0.7442360795300229
- Mean Citation Score: 295.60842
- Max Citation Score: 350.3713
- Similarity Product: 204.604890683806

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test